Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × INDUSTRY × NSCLC × Clear all

Phase

Status

Completed 10 Terminated 9 Unknown 7 Recruiting 7 Active not recruiting 4 Withdrawn 3 Not yet recruiting 3 Suspended 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 18 Breast Neoplasms 9 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Melanoma 6 Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Solid Tumors 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Multiple Myeloma 2 Mesothelioma 2 Lymphoma, T-Cell 2 Liver Neoplasms 2 Glioma 2

Interventions

HM781-36B 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05378763 2026-02-18

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡